1. Scrip
  3. >>India

Can Zydus Cadila’s COVID-19 Vaccine Win First Pediatric Approval In India?

Saroglitazar PBC Filing By Early 2024

 
• By Vibha Ravi

Unless Pfizer or Moderna beat the company to it, Zydus Cadila’s COVID-19 vaccine candidate could be India’s first such jab approved for children. With superior thermostability and proposed economical pricing, it will be one to watch, though a three-dose regimen could be a dampener. Meanwhile, saroglitazar sees slow progress.

Teenager getting vaccinated
Pediatric COVID-19 Vaccines Are Expected To Be In Demand Ahead Of The Next Wave In India • Source: Alamy (Alamy Stock Photo)

Zydus Cadila is set to have the fourth COVID-19 vaccine approved for use in India, if Pfizer Inc. and Moderna, Inc. don’t beat it to the gate.

Interim data from Phase III trials of its candidate are expected as early as two weeks from now, with plans to seek an accelerated or emergency use authorization (EUA) soon after

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia